Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
2(67%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
3
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

3

all time

Status Distribution
Active(2)
Completed(1)

Detailed Status

Recruiting2
Completed1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
2
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

completed133%
recruiting267%

Recent Activity

2 active trials
Showing 3 of 3
completednot_applicable

Acute Intermittent Hypoxia to Improve Airway Protection in Chronic Traumatic Brain Injury

NCT06520358
recruitingnot_applicable

Hypoxia Pathways for Early Recovery After Spinal Cord Injury

NCT07002437
recruitingnot_applicable

BioFLO for Respiratory Recovery in SCI

NCT06011876

Clinical Trials (3)

Showing 3 of 3 trials
NCT06520358Not Applicable

Acute Intermittent Hypoxia to Improve Airway Protection in Chronic Traumatic Brain Injury

Completed
NCT07002437Not Applicable

Hypoxia Pathways for Early Recovery After Spinal Cord Injury

Recruiting
NCT06011876Not Applicable

BioFLO for Respiratory Recovery in SCI

Recruiting

All 3 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
3